pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-433 |
Genomic Coordinates | chr14: 100881886 - 100881978 |
Synonyms | MIRN433, hsa-mir-433, miRNA433, MIR433 |
Description | Homo sapiens miR-433 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-433-3p | ||||||||||||
Sequence | 64| AUCAUGAUGGGCUCCUCGGUGU |85 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | WDR45B | ||||||||||||||||||||
Synonyms | WDR45L, WIPI-3, WIPI3 | ||||||||||||||||||||
Description | WD repeat domain 45B | ||||||||||||||||||||
Transcript | NM_019613 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on WDR45B | |||||||||||||||||||||
3'UTR of WDR45B (miRNA target sites are highlighted) |
>WDR45B|NM_019613|3'UTR 1 CTCCAGCTGGGGGCGCCACAGCACCCACCACCTGCCGCCTTCAGACTCTCGGGGCTGGTGCCAGTGCCCCAGGGGCCTCC 81 TGGGCCACGGGCTGGAGGGGCTGCCCAGGGACCTTGGTCTCGAAGCCATACGTGGTTGTCTGCTTTCCTAAGGACTCCCA 161 TTTCCAGTATTAAAGAGAGAATCATCATCAAGGCACCGTAGGTAACTCAGTGGCTGTGACCAGCTCGACTGGCGGCCACT 241 GGCTGTTCCCATGAGTTCAGCTGTGACGTTAGCTTCAGTGGCTCCGCCGCATCCTCACACTGACGGGGGCTCCATACGGA 321 CCTGGGGACTGGGCTGAGAGGGTGGACGAGTTCAGGTTTGTTTTTGCAGCAGATTCCGTCGTTCTTACTGAGTCTGCAGC 401 GGGGGAGTGAACAAGTGTGCAGATGTAAGTTCTTACATGATAAGCAGATTGAATACAACACCAGCAGCTTGCCTTAGAAA 481 AGGAGAAAGGAATTCCTTTTCCCGCCCGAACATGAAGAAAAATGACCTGACCCTGTAGAGAGAACACAGTGTGAATGTTT 561 CCCCTCGTGTGAGCCCAGCCTGTGGTCTTCTCCGTACCCGCAACGTGGTCATCTGTGCCCGTGACGTCACCTGTGCCCGT 641 GCGTGGCGTCCCCGTCTCCGTTGGGGCCATTAGAATGAGGCAGACACCAGGCCACTCTAGAAGCCGAGCCGTCACACCTC 721 AGGCGTGTGCGGGGCGGGGACGGGGGGTCTCCTGGTTACATTTTGGATTAAACCTGTTTCCCGGTTATGTGTAGGGAACA 801 GCAGAGTGATGCACGAACTTTGAACATTCGTTATGGGGAAAACATCCTTTAACTTCGGGGTCGTCTGCCAGAGCAGGGTC 881 TGGGAGGGTCCATGCAGTTCCCGCTGGTGTGGAGGGAAATGCCCTGGTCTGGCCTCCGAGCCCCCAGGTCCACCGTCTCC 961 CCTCCCCTCATTTGTAAGAATAGCTACACACTAACATTTTGGGAAGGAGAGGCACATAACTTTTTTTAACATTTGGTAAC 1041 TAGGTTATGGGCTCTACATTGTCAGCTACTTGGGATATATATTTAATTTTCTTAAATTCCCGTTAAACTCTATTTTATGG 1121 TTTTGATTTCAGATTGCAAACATGTAAAACCTGCATAGCAGCGAGTTCTCGGTTTTGCCGGTTTCTTTAGTTCTTTACTG 1201 TCACTGTCATGTAATCAGCTAATTCTCTGTGGATGTTGCTGTAAAGTATGCATGTTCCTTTCATGTGTATTTAATCATGA 1281 TGTTTAATTTTGCACACTTATTTGTAATGTTTCTTTTAAATAAAAGTGACTAATTTTGTTGTAGTCTGGACCTGTAAAAA 1361 AAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000392325.4 | 3UTR | UAUUUAAUCAUGAUGUUUAAUUUUGCACACUUAUUUGUAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
75 hsa-miR-433-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT001201 | GRB2 | growth factor receptor bound protein 2 | 3 | 1 | ||||||||
MIRT001741 | FGF20 | fibroblast growth factor 20 | 3 | 1 | ||||||||
MIRT007225 | RUNX2 | runt related transcription factor 2 | 1 | 1 | ||||||||
MIRT007361 | CFTR | cystic fibrosis transmembrane conductance regulator | 1 | 1 | ||||||||
MIRT016630 | HDAC6 | histone deacetylase 6 | 1 | 1 | ||||||||
MIRT053561 | KRAS | KRAS proto-oncogene, GTPase | 3 | 1 | ||||||||
MIRT082022 | COX6B1 | cytochrome c oxidase subunit 6B1 | 2 | 4 | ||||||||
MIRT086929 | CREB1 | cAMP responsive element binding protein 1 | 3 | 1 | ||||||||
MIRT096407 | C5ORF22 | chromosome 5 open reading frame 22 | 2 | 2 | ||||||||
MIRT135569 | SPRYD4 | SPRY domain containing 4 | 2 | 2 | ||||||||
MIRT143520 | CHD9 | chromodomain helicase DNA binding protein 9 | 2 | 2 | ||||||||
MIRT167706 | HIVEP1 | human immunodeficiency virus type I enhancer binding protein 1 | 2 | 8 | ||||||||
MIRT207568 | STARD7 | StAR related lipid transfer domain containing 7 | 2 | 4 | ||||||||
MIRT252052 | WDR45B | WD repeat domain 45B | 2 | 2 | ||||||||
MIRT327787 | YIPF6 | Yip1 domain family member 6 | 2 | 2 | ||||||||
MIRT406144 | SERBP1 | SERPINE1 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT437355 | GBP2 | guanylate binding protein 2 | 3 | 1 | ||||||||
MIRT438242 | TYMS | thymidylate synthetase | 3 | 1 | ||||||||
MIRT438553 | AZIN1 | antizyme inhibitor 1 | 4 | 1 | ||||||||
MIRT444186 | SCAMP1 | secretory carrier membrane protein 1 | 2 | 2 | ||||||||
MIRT477737 | EDN1 | endothelin 1 | 2 | 2 | ||||||||
MIRT483052 | SMU1 | DNA replication regulator and spliceosomal factor | 2 | 2 | ||||||||
MIRT485778 | ATXN1 | ataxin 1 | 2 | 2 | ||||||||
MIRT498142 | FKBP1C | FK506 binding protein 1C | 2 | 4 | ||||||||
MIRT499050 | SSC5D | scavenger receptor cysteine rich family member with 5 domains | 2 | 8 | ||||||||
MIRT501959 | MAPK8 | mitogen-activated protein kinase 8 | 2 | 2 | ||||||||
MIRT503281 | TMEM229B | transmembrane protein 229B | 2 | 4 | ||||||||
MIRT503597 | ZNF780A | zinc finger protein 780A | 2 | 2 | ||||||||
MIRT504577 | UGT2B4 | UDP glucuronosyltransferase family 2 member B4 | 2 | 4 | ||||||||
MIRT506727 | LONRF2 | LON peptidase N-terminal domain and ring finger 2 | 2 | 2 | ||||||||
MIRT523130 | HSP90B1 | heat shock protein 90 beta family member 1 | 2 | 4 | ||||||||
MIRT531338 | TGIF2LX | TGFB induced factor homeobox 2 like, X-linked | 2 | 2 | ||||||||
MIRT534928 | PTPLAD1 | 3-hydroxyacyl-CoA dehydratase 3 | 1 | 1 | ||||||||
MIRT536233 | LRIG3 | leucine rich repeats and immunoglobulin like domains 3 | 2 | 2 | ||||||||
MIRT537092 | GPR135 | G protein-coupled receptor 135 | 2 | 2 | ||||||||
MIRT548286 | FAM3C | family with sequence similarity 3 member C | 2 | 4 | ||||||||
MIRT549143 | BRWD1 | bromodomain and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT556354 | MAFK | MAF bZIP transcription factor K | 2 | 2 | ||||||||
MIRT557839 | FKBP1A | FK506 binding protein 1A | 2 | 2 | ||||||||
MIRT564080 | NSA2 | NSA2, ribosome biogenesis homolog | 2 | 2 | ||||||||
MIRT566382 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 2 | ||||||||
MIRT573110 | ERBB2IP | erbb2 interacting protein | 2 | 2 | ||||||||
MIRT574403 | TFAP2A | transcription factor AP-2 alpha | 2 | 2 | ||||||||
MIRT576063 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT619449 | TCF20 | transcription factor 20 | 2 | 2 | ||||||||
MIRT632928 | FGF9 | fibroblast growth factor 9 | 2 | 2 | ||||||||
MIRT633216 | ZNF584 | zinc finger protein 584 | 2 | 2 | ||||||||
MIRT633654 | SLC28A1 | solute carrier family 28 member 1 | 2 | 2 | ||||||||
MIRT637198 | KLHL4 | kelch like family member 4 | 2 | 2 | ||||||||
MIRT646480 | SPATS2L | spermatogenesis associated serine rich 2 like | 2 | 2 | ||||||||
MIRT648314 | SCNN1G | sodium channel epithelial 1 gamma subunit | 2 | 2 | ||||||||
MIRT648631 | LEMD2 | LEM domain containing 2 | 2 | 2 | ||||||||
MIRT655902 | NEK9 | NIMA related kinase 9 | 2 | 2 | ||||||||
MIRT667805 | ITIH5 | inter-alpha-trypsin inhibitor heavy chain family member 5 | 2 | 2 | ||||||||
MIRT675464 | NUBPL | nucleotide binding protein like | 2 | 2 | ||||||||
MIRT675974 | FAM126B | family with sequence similarity 126 member B | 2 | 2 | ||||||||
MIRT676145 | ALDOA | aldolase, fructose-bisphosphate A | 2 | 2 | ||||||||
MIRT676895 | GABPB1 | GA binding protein transcription factor beta subunit 1 | 2 | 2 | ||||||||
MIRT677459 | PDLIM3 | PDZ and LIM domain 3 | 2 | 2 | ||||||||
MIRT677533 | TM4SF5 | transmembrane 4 L six family member 5 | 2 | 2 | ||||||||
MIRT677641 | HAUS2 | HAUS augmin like complex subunit 2 | 2 | 2 | ||||||||
MIRT678806 | HRH4 | histamine receptor H4 | 2 | 2 | ||||||||
MIRT679693 | SLC1A5 | solute carrier family 1 member 5 | 2 | 4 | ||||||||
MIRT679707 | RPL24 | ribosomal protein L24 | 2 | 2 | ||||||||
MIRT698822 | STK38 | serine/threonine kinase 38 | 2 | 2 | ||||||||
MIRT701796 | MRPS25 | mitochondrial ribosomal protein S25 | 2 | 2 | ||||||||
MIRT702220 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT706095 | ENTPD4 | ectonucleoside triphosphate diphosphohydrolase 4 | 2 | 2 | ||||||||
MIRT706502 | MTMR9 | myotubularin related protein 9 | 2 | 2 | ||||||||
MIRT709780 | NINJ1 | ninjurin 1 | 2 | 2 | ||||||||
MIRT713859 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 2 | ||||||||
MIRT715807 | BBS2 | Bardet-Biedl syndrome 2 | 2 | 2 | ||||||||
MIRT724229 | DGKE | diacylglycerol kinase epsilon | 2 | 2 | ||||||||
MIRT731338 | MET | MET proto-oncogene, receptor tyrosine kinase | 1 | 1 | ||||||||
MIRT731849 | HIF1A | hypoxia inducible factor 1 alpha subunit | 3 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|